FDA
approval
· 2024-11-07
FDA Approved: DELSTRIGO — Supplemental Application (Merck Sharp & Dohme LLC)
Summary
FDA approved a supplemental application for Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) submitted by Merck, resulting in updated labeling fo…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DELSTRIGO (DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE)